Implication of oxidative stress-induced oncogenic signaling pathways as a treatment strategy for neurodegeneration and cancer

Systems Biology of Free Radicals and Antioxidants

Volumn , Issue , 2012, Pages 2325-2347

  Aliev, Gjumrakch ^a,b   Burzynski, Gregory ^c   Ashraf, Ghulam Md ^d   Jabir, Nasimudeen R ^d   Cacabelos, Ramon ^e   Benberin, Valery V ^f   Burzynski, Stanislaw R ^c  

^a GALLY International Biomedical Research Consulting LLC   (United States)

^b University of Atlanta   (United States)

^c Burzynski Clinics Burzynski Research Institute   (United States)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^e CAMILO JOSÉ CELA UNIVERSITY   (Spain)

^f Medical Center of the Administration of the President of the Republic of Kazakhstan   (Kazakhstan)

Author keywords

Alzheimer's disease; Cancer; Cell Cycle; Mitochondria; Oncogenes; Oxidative stress

Indexed keywords

EID: 84929138425     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-30018-9_206     Document Type: Chapter

References (75)

1. Aliev G, Obrenovich ME, Tabrez S, Jabir NR, Reddy VP, Li Y, Burnstock G, Cacabelos R, Kamal MA (2013) Link between cancer and alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletion. Oxidative Medicine and Cellular Longevity. vol. 2013, Article ID 962984, 19 pages, 2013. doi:10.1155/2013/962984
2. Aliev G, Palacios HH, Cacabelos P, Cacabelos R, Burzynski G, Burzynski SR (2012) Mitochondria specific antioxidants and their derivatives in the context of the drug development for neurodegeneration and cancer. Drug Des 2 (103). doi: 10.4172/2169-0138.100010370
3. Andorfer C, Acker CM, Kress Y, Hof PR, Duff K, Davies P (2005) Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J Neurosci 25(22):5446-5454. doi:10.1523/jneurosci.4637-04.2005
4. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW (2004) Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 101(7):2173-2178. doi:10.1073/pnas. 0308512100
5. Bonda DJ, Bajić VP, Spremo-Potparevic B, Casadesus G, Zhu X, Smith MA, Lee HG (2010) Review: cell cycle aberrations and neurodegeneration. Neuropathol Appl Neurobiol 36(2):157-163. doi:10.1111/j.1365-2990.2010.01064.x
6. Bretaud S, Allen C, Ingham PW, Bandmann O (2007) p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease. J Neurochem 100(6):1626-1635. doi:10.1111/j.1471-4159.2006.04291.x
7. Causeret F, Terao M, Jacobs T, Nishimura YV, Yanagawa Y, Obata K, Hoshino M, Nikolic M (2009) The p21-Activated kinase is required for neuronal migration in the cerebral cortex. Cerebral Cortex (New York, NY) 19(4):861-875. doi:10.1093/cercor/bhn133
8. Chen H-K, Fernandez-Funez P, Acevedo SF, Lam YC, Kaytor MD, Fernandez MH, Aitken A, Skoulakis EMC, Orr HT, Botas J, Zoghbi HY (2003) Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 113(4):457-468
9. Clements CM, McNally RS, Conti BJ, Mak TW, Ting JPY (2006) DJ-1, a cancer-And Parkinson's disease-Associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. PNAS 103(41):15091-15096. doi:10.1073/pnas.0607260103
10. Crampton N, Kodiha M, Shrivastava S, Umar R, Stochaj U (2009) Oxidative stress inhibits nuclear protein export by multiple mechanisms that target FG nucleoporins and Crm1. Mol Biol Cell 20(24):5106-5116. doi:10.1091/mbc.E09-05-0397
11. Cruz JC, Kim D, Moy LY, Dobbin MM, Sun X, Bronson RT, Tsai L-H (2006) p25/cyclindependent kinase 5 induces production and intraneuronal accumulation of amyloid b in vivo. J Neurosci 26(41):10536-10541. doi:10.1523/jneurosci.3133-06.2006
12. Cully M, You H, Levine AJ, Mak TW (2006) Beyond PTEN mutations: The PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6(3):184-192. doi:10.1038/nrc1819
13. D'Angelo MA, Raices M, Panowski SH, Hetzer MW (2009) Age-dependent deterioration of nuclear pore complexes causes a loss of nuclear integrity in postmitotic cells. Cell 136(2):284-295. doi:10.1016/j.cell.2008.11.037
14. Delgado-Esteban M, Martin-Zanca D, Andres-Martin L, Almeida A, Bolanõs JP (2007) Inhibition of PTEN by peroxynitrite activates the phosphoinositide-3-kinase/Akt neuroprotective signaling pathway. J Neurochem 102(1):194-205. doi:10.1111/j.1471-4159.2007.04450.x
15. Ding Y, Qiao A, Wang Z, Goodwin JS, Lee E-S, Block ML, Allsbrook M, McDonald MP, Fan G-H (2008) Retinoic acid attenuates b-Amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J Neurosci 28(45):11622-11634. doi:10.1523/jneurosci.3153-08.2008
16. Evans TA (2007) BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease. Int J Med Sci. doi:10.7150/ijms.4.140
17. Fallon L, Bélanger CML, Corera AT, Kontogiannea M, Regan-Klapisz E, Moreau F, Voortman J, Haber M, Rouleau G, Thorarinsdottir T, Brice A, van Bergen En Henegouwen PMP, Fon EA (2006) A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling. Nat Cell Biol 8(8):834-842. doi:10.1038/ncb1441
18. Franco S, Blasco MA, Siedlak SL, Harris PLR, Moreira PI, Perry G, Smith MA (2006) Telomeres and telomerase in Alzheimer's disease: epiphenomena or a new focus for therapeutic strategy? Alzheimer's Dement 2(3):164-168. doi:10.1016/j.jalz.2006.03.001
19. Gautier CA, Kitada T, Shen J (2008) Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci USA 105(32):11364-11369. doi:10.1073/pnas.0802076105
20. Giaime E, Sunyach C, Druon C, Scarzello S, Robert G, Grosso S, Auberger P, Goldberg MS, Shen J, Heutink P, Pouyssegur J, Pages G, Checler F, Ad C (2010) Loss of function of DJ-1 triggered by Parkinson's disease-Associated mutation is due to proteolytic resistance to caspase-6. Cell Death Differ 17(1):158-169. doi:10.1038/cdd.2009.116
21. Giovanni A, Wirtz-Brugger F, Keramaris E, Slack R, Park DS (1999) Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F • DP, in B-Amyloid-induced neuronal death. J Biol Chem 274(27):19011-19016. doi:10.1074/jbc.274.27.19011
22. Görner K, Holtorf E, Waak J, Pham T-T, Vogt-Weisenhorn DM, Wurst W, Haass C, Kahle PJ (2007) Structural determinants of the C-terminal helix-kink-helix motif essential for protein stability and survival promoting activity of DJ-1. J Biol Chem 282(18):13680-13691. doi:10.1074/jbc.M609821200
23. Griffin RJ, Moloney A, Kelliher M, Johnston JA, Ravid R, Dockery P, O'Connor R, O'Neill C (2005) Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J Neurochem 93(1):105-117. doi:10.1111/j.1471-4159.2004.02949.x
24. H-g L, Casadesus G, Zhu X, Castellani RJ, McShea A, Perry G, Petersen RB, Bajic V, Smith MA (2009) Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease. Neurochem Int 54(2):84-88. doi:10.1016/j.neuint.2008.10.013
25. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA (2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci Off J Soc Neurosci 21(9):3017-3023
26. Ho L, Ferruzzi MG, Janle EM, Wang J, Gong B, Chen TY, Lobo J, Cooper B, Wu QL, Talcott ST, Percival SS, Simon JE, Pasinetti GM (2013) Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease. FASEB J 27(2):769-781
27. Hong SY, Jeong WS, Jun M (2012) Protective effects of the key compounds isolated from Corni fructus against b-Amyloid-induced neurotoxicity in PC12 cells. Molecules 17(9):10831-10845
28. Inden M, Taira T, Kitamura Y, Yanagida T, Tsuchiya D, Takata K, Yanagisawa D, Nishimura K, Taniguchi T, Kiso Y, Yoshimoto K, Agatsuma T, Koide-Yoshida S, Iguchi-Ariga SMM, Shimohama S, Ariga H (2006) PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. Neurobiol Dis 24(1):144-158. doi:10.1016/j.nbd.2006.06.004
29. Junn E, Taniguchi H, Jeong BS, Zhao X, Ichijo H, MouradianMM(2005) Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc Natl Acad Sci USA 102(27):9691-9696. doi:10.1073/pnas.0409635102
30. Kim RH, Mak TW (2006) Tumours and tremors: how PTEN regulation underlies both. Br J Cancer 94(5):620-624. doi:10.1038/sj.bjc.6602994
31. Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, Pownall S, Wakeham A, You-Ten AJ, Kalia SK, Horne P, Westaway D, Lozano AM, Anisman H, Park DS, Mak TW (2005) Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci USA 102(14):5215-5220. doi:10.1073/pnas.0501282102
32. Kinumi T,Kimata J, Taira T, ArigaH,Niki E (2004)Cysteine-106 of DJ-1 is themost sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem Biophys Res Commun 317(3):722-728. doi:10.1016/j.bbrc.2004.03.110
33. Klein JA, Ackerman SL (2003) Oxidative stress, cell cycle, and neurodegeneration. J Clin Invest 111(6):785-793. doi:10.1172/jci18182
34. Konishi Y, Lehtinen M, Donovan N, Bonni A (2002) Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. Mol Cell 9(5):1005-1016
35. Korhonen L, Brännvall K, Skoglösa Y, Lindholm D (2003) Tumor suppressor gene BRCA-1 is expressed by embryonic and adult neural stem cells and involved in cell proliferation. J Neurosci Res 71(6):769-776
36. Kotwaliwale CV, Dernburg AF (2009) Old nuclei spring new leaks. Cell 136(2):211-212. doi:10.1016/j.cell.2009.01.004
37. Kumar R, Gururaj AE, Barnes CJ (2006) p21-Activated kinases in cancer. Nat Rev Cancer 6(6):459-471
38. Kuroda Y, Mitsui T, Kunishige M, Shono M, Akaike M, Azuma H, Matsumoto T (2006) Parkin enhances mitochondrial biogenesis in proliferating cells. Hum Mol Genet 15(6):883-895. doi:10.1093/hmg/ddl006
39. Ledoux S, Rebai N, Dagenais A, Shaw IT, Nalbantoglu J, Sekaly RP, Cashman NR (1993) Amyloid precursor protein in peripheral mononuclear cells is up-regulated with cell activation. J Immunol 150(12):5566-5575
40. Maehama T, Taylor GS, Dixon JE (2001) PTEN and myotubularin: novel phosphoinositide phosphatases. Annu Rev Biochem 70:247-279. doi:10.1146/annurev.biochem.70.1.247
41. Malik B, Currais A, Andres A, Towlson C, Pitsi D, Nunes A, Niblock M, Cooper J, Hortobágyi T, Soriano S (2008) Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the presenilin-1 Alzheimer's disease brain. Cell cycle (Georgetown, Tex) 7(5):637-646
42. Mattson MP, Guo Q, Furukawa K, Pedersen WA (1998) Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J Neurochem 70(1):1-14
43. McDonald DR, Bamberger ME, Combs CK, Landreth GE (1998) b-Amyloid fibrils activate parallel mitogen-Activated protein kinase pathways in Microglia and THP1 monocytes. J Neurosci 18(12):4451-4460
44. McPherson JP, Hande MP, Poonepalli A, Lemmers B, Zablocki E, Migon E, Shehabeldin A, Porras A, Karaskova J, Vukovic B, Squire J, Hakem R (2006) A role for Brca1 in chromosome end maintenance. Hum Mol Genet 15(6):831-838. doi:10.1093/hmg/ddl002
45. McShea A, Lee HG, Petersen RB, Casadesus G, Vincent I, Linford NJ, Funk JO, Shapiro RA, Smith MA (2007) Neuronal cell cycle re-entry mediates Alzheimer disease-type changes. Biochim Biophys Acta 1772(4):467-472. doi:10.1016/j.bbadis.2006.09.010
46. Meng J, Meng Y, Hanna A, Janus C, Jia Z (2005) Abnormal long-lasting synaptic plasticity and cognition in mice lacking the mental retardation gene Pak3. J Neurosci 25(28):6641-6650
47. Meulener MC, Xu K, Thomson L, Ischiropoulos H, Bonini NM (2006) Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging. PNAS 103(33):12517-12522. doi:10.1073/pnas.0601891103
48. Morris LGT, Veeriah S, Chan TA (2010) Genetic determinants at the interface of cancer and neurodegenerative disease. Oncogene 29(24):3453-3464. doi:10.1038/onc.2010.127
49. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60(8):759-767
50. Obrenovich ME, Li Y, Parvathaneni K, Yendluri BB, Palacios HH, Leszek J, Aliev G (2011) Antioxidants in health, disease and aging. CNS Neurol Disord Drug Targets 10(2):192-207
51. Park KHJ, Hallows JL, Chakrabarty P, Davies P, Vincent I (2007) Conditional neuronal Simian Virus 40 T antigen expression induces Alzheimer-Like Tau and Amyloid pathology in mice. J Neurosci 27(11):2969-2978. doi:10.1523/jneurosci.0186-07.2007
52. Pisani A, Martella G, Tscherter A, Costa C, Mercuri NB, Bernardi G, Shen J, Calabresi P (2006) Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K + ATPase. Neurobiol Dis 23(1):54-60. doi:10.1016/j.nbd.2006.02.001
53. Raina AK, Zhu X, Rottkamp CA, Monteiro M, Takeda A, Smith MA (2000) Cyclin' toward dementia. J Neurosci Res 61(2):128-133. doi:10.1002/1097-4547(20000715)61:2<128::aidjnr2> 3.0.co;2-h
54. Rickle A, Bogdanovic N, Volkmann I, Zhou X, Pei J-J, Winblad B, Cowburn RF (2006) PTEN levels in Alzheimer's disease medial temporal cortex. Neurochem Int 48(2):114-123. doi:10.1016/j.neuint.2005.08.014
55. Ries V, Henchcliffe C, Kareva T, Rzhetskaya M, Bland R, During MJ, Kholodilov N, Burke RE (2006) Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease. Proc Natl Acad Sci USA 103(49):18757-18762. doi:10.1073/pnas.0606401103
56. Sheweita SA, Sheikh BY (2011) Can dietary antioxidants reduce the incidence of brain tumors? Curr Drug Metab 12(6):587-593
57. Sieradzki A, Yendluri BB, Palacios HH, Parvathaneni K, Reddy VP, Obrenovich ME, Gąsiorowski K, Leszek J, Aliev G (2011) Implication of oncogenic signaling pathways as a treatment strategy for neurodegenerative disorders -contemporary approaches. CNS Neurol Disord Drug Targets 10(2):175-183
58. Suzen S (2013) Melatonin and synthetic analogs as antioxidants. Curr Drug Deliv 10(1):71-75
59. Suzuki T, Oishi M, Marshak DR, Czernik AJ, Nairn AC, Greengard P (1994) Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. EMBO J 13(5):1114-1122
60. Teixeira J, Silva T, Andrade PB, Borges F (2013) Alzheimer disease and antioxidant therapy: how long how far? Curr Med Chem 20(24):2939-2952
61. Thomas B, Beal MF (2007) Parkinson's disease. Hum Mol Genet 16 Spec No. 2:R183-194. doi:10.1093/hmg/ddm159
62. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MMK, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, González-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304(5674):1158-1160. doi:10.1126/science.1096284
63. Vasseur S, Afzal S, Tardivel-Lacombe J, Park DS, Iovanna JL, Mak TW (2009) DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses. Proc Natl Acad Sci USA 106(4):1111-1116. doi:10.1073/pnas.0812745106
64. Vincent I, Jicha G, Rosado M, Dickson DW (1997) Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci Off J Soc Neurosci 17(10):3588-3598
65. Wang W, Bu B, Xie M, Zhang M, Yu Z, Tao D (2009) Neural cell cycle dysregulation and central nervous system diseases. Prog Neurobiol 89(1):1-17. doi:10.1016/j.pneurobio.2009.01.007
66. Wang X, Su B, Fujioka H, Zhu X (2008) Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. Am J Pathol 173(2):470-482. doi:10.2353/ajpath.2008.071208
67. Wei W, Wang X, Kusiak JW (2002) Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protection. J Biol Chem 277(20):17649-17656. doi:10.1074/jbc.M111704200
68. Woods J, Snape M, Smith MA (2007) The cell cycle hypothesis of Alzheimer's disease: suggestions for drug development. Biochim Biophys Acta 1772(4):503-508. doi:10.1016/j. bbadis.2006.12.004
69. Yang Y, Gehrke S, Haque ME, Imai Y, Kosek J, Yang L, Beal MF, Nishimura I, Wakamatsu K, Ito S, Takahashi R, Lu B (2005) Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc Natl Acad Sci USA 102(38):13670-13675. doi:10.1073/pnas.0504610102
70. Zhong N, Kim CY, Rizzu P, Geula C, Porter DR, Pothos EN, Squitieri F, Heutink P, Xu J (2006) DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-Associated splicing factor. J Biol Chem 281(30):20940-20948. doi:10.1074/jbc.M601935200
71. Zhou W, Zhu M, Wilson MA, Petsko GA, Fink AL (2006) The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. J Mol Biol 356(4):1036-1048. doi:10.1016/j. jmb.2005.12.030
72. Zhu X, H-g L, Perry G, Smith MA (2007) Alzheimer disease, the two-hit hypothesis: an update. Biochim Biophys Acta 1772(4):494-502. doi:10.1016/j.bbadis.2006.10.014
73. Zhu X, Raina AK, Rottkamp CA, Aliev G, Perry G, Boux H, Smith MA (2001) Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J Neurochem 76(2):435-441
74. Zhu X, Siedlak SL, Wang Y, Perry G, Castellani RJ, Cohen ML, Smith MA (2008) Neuronal binucleation in Alzheimer disease hippocampus. Neuropathol Appl Neurobiol 34(4):457-465. doi:10.1111/j.1365-2990.2007.00908.x
75. Zhu Y, Hoell P, Ahlemeyer B, Krieglstein J (2006) PTEN: A crucial mediator of mitochondriadependent apoptosis. Apoptosis 11(2):197-207. doi:10.1007/s10495-006-3714-5